GLP-1s explained
GLP-1 weight loss,
explained like a human.
What the medication actually does in your body. What the research shows. And a free tool that maps a realistic projection for you. No jargon, no hype, no email required.
The short version
- What GLP-1 is
- A hormone your gut already makes after you eat. It tells your brain you’re full and slows your stomach down.
- What the medication does
- Turns that signal back up when your own runs weak. Appetite drops, and food noise gets quiet.
- Why diets failed
- Food noise is hormone signalling, not willpower. Discipline was never the missing piece.
- What it doesn’t do
- Protect your muscle. That takes protein and resistance training, not medication.
- How long it takes
- Appetite usually calms in the first week or two. The scale moves fastest early, then steadies.
- Who decides if you qualify
- A licensed physician, after reviewing your health history. Not a quiz, and not this page.
What a GLP-1 actually does.
GLP-1 stands for glucagon-like peptide-1. Your gut already makes it. After you eat, it tells your brain you’re full and tells your stomach to slow down.
The problem is that for a lot of people, that signal runs weak. Hunger comes back fast. Cravings pile up. The scale won’t move no matter how carefully you eat.
GLP-1 medication turns that signal back up. You feel full sooner. You stay full longer. And for the first time in years, eating less stops feeling like a daily fight. It’s not magic. It’s biology finally working with you instead of against you.
Tirzepatide goes one step further. It works on two receptors instead of one — GLP-1 and GIP. That second pathway acts on fat cells directly, which is why it’s called dual-action, and it’s the medication our core program is built around.
Why the food noise goes quiet.
“Food noise” is the running commentary in your head about food. What to eat, when, whether you should, why you did. For a lot of people it never fully switches off.
Here’s the part that matters: it’s driven by hormones, not by a lack of willpower. The receptors that respond to GLP-1 sit in the parts of your brain that drive food-seeking and reward. When the medication reaches them, the urgency drops.
Which explains why discipline alone kept failing. You weren’t losing a willpower contest. You were being asked to out-argue a hormone.
Struggling with weight is a medical thing, not a moral failing.
Why medication alone isn’t enough.
This is where most companies stop. They ship a vial. They wish you luck. Then they go quiet.
The medication solves appetite. It doesn’t teach your body what to do with the calories you still need. It doesn’t protect your muscle while the fat comes off. It doesn’t walk you through week two, or the plateau in month three, or the question of what happens when you stop.
Those parts need a plan and a person. So while the vial does its job, we do ours — keeping your protein high, your energy up, and the weight you lose coming from fat.
Protecting your muscle is the whole game.
This matters more than almost anyone tells you. When you lose weight quickly, some of it can come from muscle. And muscle is what keeps your metabolism strong, your body capable, and the weight from creeping back later.
The medication does not handle this for you. Two things do: eating enough protein, and keeping your muscles working.
So our plan builds both in from day one. Protein targets you can actually hit, and simple strength guidance that fits a real schedule. Not a boot camp. Just enough to keep what matters.
Side effects, honestly.
Most people feel something in the first few weeks. Usually mild nausea, fullness, or a change in digestion.
Some of that is the medication doing exactly what it’s meant to do — slowing your stomach down is the mechanism, not a malfunction. But how much you feel it is strongly shaped by things you control: portion sizes, how fast you eat, hydration, and how carefully your dose is managed. That’s why our plan front-loads all of it.
You shouldn’t have to guess your way through. When something feels off, you message us, and we adjust the plan around it. That support is the difference between quitting in week three and getting to week twelve.
Where our lane ends. Nutrition, movement and hydration are ours as dietitians. Your dose, a missed injection, or symptoms you’re having right now go to your prescribing physician. If anything feels severe or urgent, contact them or emergency services right away.
Who this is — and isn’t — for.
This fits adults ready to treat weight as the medical thing it is. It fits people who’ve tried the diets and want a supported path instead. And it fits anyone who wants a clinician in their corner, not just a checkout button.
It isn’t for everyone. Eligibility depends on your health history, and a licensed physician makes that call after reviewing your intake — not a web page and not a quiz. Some people won’t qualify, and we’ll tell you straight either way.
The evidence
Why a GLP-1 works when diets don’t.
Willpower diets ask your body to fight its own biology. GLP-1 medication changes the biology itself — it slows digestion, steadies blood sugar, and turns down the constant hum of hunger.
The chart says it plainly. In their major clinical trials, people on a GLP-1 lost several times more weight than people relying on diet and lifestyle changes alone.
- 22.5% average loss on tirzepatide at 72 weeks SURMOUNT-1
- 14.9% average loss on semaglutide at 68 weeks STEP-1
- ~2–3% average loss in the placebo arms lifestyle counselling
Sources: SURMOUNT-1, N Engl J Med 2022 · STEP-1, N Engl J Med 2021. Placebo arms included lifestyle counselling. These are trial averages, not guarantees — individual results vary with dose, adherence, and individual response.
Free tool · built on trial data
See your GLP-1 weight-loss projection.
Enter your starting weight and pick a medication. We’ll map a likely trajectory against the published trial curves. No email required to see it.
Model basis: mean percentage body-weight change from SURMOUNT-1 (tirzepatide 15 mg, 22.5% at week 72; N Engl J Med 2022) and STEP-1 (semaglutide 2.4 mg, 14.9% at week 68; N Engl J Med 2021), scaled to the goal you select. Your own results depend on dose, adherence, and individual response, and a licensed physician determines whether treatment is appropriate for you.